Ozempic (semaglutide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus only
Composed of 15 amino acids, this pentadecapeptide has been shown in research to stimulate angiogenesis, collagen formation, and tissue remodeling.- It may interact with nitric oxide pathways, growth factor expression, and inflammatory cascades to support endothelial function and cellular recovery.- Suggested mechanisms include upregulation of VEGF, engagement with FAK-paxillin signaling, and protective effects under oxidative stress conditions
Tirzepatide (GLP-1/GIP) Tirzepatide is a first-in-class dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 receptor agonist, providing synergistic metabolic effects for diabetes and obesity research
Superoxide dismutase (SOD) and catalase (CAT) are typically upregulated in response to oxidative stress, and their dysregulation has been implicated in metabolic disorders
Those with symptomatic gallstone diseasepain, nausea, or recurrent episodesshould either have the gallbladder removed before starting GLP-1 therapy or pursue non-surgical weight loss methods
One area of interest is peptide therapy